Source: Yahoo News
VMD Sciences, LLC has launched its Expanded Access Programs (EAPs) for pets and livestock, providing veterinarians with access to advanced, life-saving treatments that are otherwise unavailable. In collaboration with community veterinarians and animal medicine developers, the company aims to address unmet medical needs through responsible extra-label drug use. These EAPs, modeled after human “Compassionate Use” programs, offer hope for animals when traditional treatments fail.
VMD Sciences helps ensure safe, compliant access to global Veterinary medicines by supporting regulatory filings and adhering to global guidelines. Their ethical drug sourcing and global network connect veterinarians to unlicensed but promising treatments. In addition, the company supports community veterinarians through clinical trials and AI-driven tools, enhancing the health of pets and livestock. VMD Sciences seeks to accelerate biomedical innovation by bridging the gap between veterinarians, pharmaceutical companies, and pet owners, promoting translational medicine for both animals and humans.
Read the full story HERE: https://finance.yahoo.com/news/vmd-sciences-launches-lifesaving-expanded-144100208.html